1. Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Clinical
Trials Support Services Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Service (Clinical Trial Site Management, Patient Recruitment Management(
Patient recruitment & registry services, Patient retention, Others), Data
Management, Administrative staff, IRB, Others)
5.2.2. By Sponsor (Pharmaceutical & Biopharmaceutical, Medical Devices,
Others)
5.2.3. By Company (2023)
5.2.4. By Region
5.3.
Market Map
6. North America
Clinical Trials Support Services Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1.
By Service
6.2.2.
By Sponsor
6.2.3. By Country
6.3.
North America: Country Analysis
6.3.1. United States
Clinical Trials Support Services Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Service
6.3.1.2.2.
By Sponsor
6.3.2. Mexico Clinical
Trials Support Services Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Service
6.3.2.2.2.
By Sponsor
6.3.3. Canada Clinical
Trials Support Services Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Service
6.3.3.2.2.
By Sponsor
7. Europe Clinical
Trials Support Services Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1.
By Service
7.2.2. By Sponsor
7.2.3. By Country
7.3.
Europe: Country Analysis
7.3.1. France Clinical
Trials Support Services Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Service
7.3.1.2.2.
By Sponsor
7.3.2. Germany Clinical
Trials Support Services Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Service
7.3.2.2.2.
By Sponsor
7.3.3. United Kingdom
Clinical Trials Support Services Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Service
7.3.3.2.2.
By Sponsor
7.3.4. Italy Clinical
Trials Support Services Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Service
7.3.4.2.2.
By Sponsor
7.3.5. Spain Clinical
Trials Support Services Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Service
7.3.5.2.2.
By Sponsor
8. Asia-Pacific
Clinical Trials Support Services Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1.
By Service
8.2.2.
By Sponsor
8.2.3. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Clinical
Trials Support Services Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Service
8.3.1.2.2.
By Sponsor
8.3.2. India Clinical
Trials Support Services Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Service
8.3.2.2.2.
By Sponsor
8.3.3. South Korea Clinical
Trials Support Services Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Service
8.3.3.2.2.
By Sponsor
8.3.4. Japan Clinical
Trials Support Services Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Service
8.3.4.2.2.
By Sponsor
8.3.5. Australia Clinical
Trials Support Services Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Service
8.3.5.2.2.
By Sponsor
9. South America
Clinical Trials Support Services Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Service
9.2.2. By Sponsor
9.2.3. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Clinical
Trials Support Services Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Service
9.3.1.2.2.
By Sponsor
9.3.2. Argentina Clinical
Trials Support Services Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Service
9.3.2.2.2.
By Sponsor
9.3.3. Colombia Clinical
Trials Support Services Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Service
9.3.3.2.2.
By Sponsor
10. Middle East and
Africa Clinical Trials Support Services Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Service
10.2.2. By Sponsor
10.2.3. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
Clinical Trials Support Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Service
10.3.1.2.2.
By Sponsor
10.3.2. Saudi Arabia Clinical
Trials Support Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Service
10.3.2.2.2.
By Sponsor
10.3.3. UAE Clinical Trials
Support Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Service
10.3.3.2.2.
By Sponsor
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends &
Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13. Porters Five Forces
Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14. Competitive
Landscape
14.1.
Charles River Laboratories International, Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products &
Services
14.1.4. Financials (As
Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel
Details
14.1.7. SWOT Analysis
14.2.
Wuxi Apptec
14.3.
IQVIA Inc.
14.4.
Syneos Health
14.5.
Eurofins Scientific
14.6.
Ppd, Inc. (Thermo Fisher Scientific Inc.)
14.7.
Icon Plc
14.8. Laboratory Corporation Of America Holdings
14.9.
Parexel International (MA) Corporation
15. Strategic
Recommendations
16. About Us & Disclaimer